Nous souhaitons féliciter tous les membres IDIGH qui ont reçu une subvention des IRSC ce printemps, notamment via le Programme de subventions Projet.
Voici la liste des projets récents subventionnés:
Soumis par les membres du programme IDIGH :
- Cheng, Matthew P; Bai, Anthony D; Daley, Peter; Daneman, Nick; Grant, Jennifer; Lawandi, Alexander; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Somayaji, Ranjani; Wuerz, Terence. A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP), 1 705 952$/4 ans
- Pai, Madhukar; Farhat, Maha. Why are women at greater risk for multi-drug resistant tuberculosis?, 1 147 500/5 ans
- Colmegna, Ines; Langlais, David; Martin, James G. Investigating the anti-fibrotic effects of human multipotent mesenchymal stromal cells, 1 040 000$/4 ans
- Lee, Todd C; Benedetti, Andrea; Bhagani, Sanjay; Boyles, Tom; Butler-Laporte, Guillaume; Cheng, Matthew P; McDonald, Emily G; McGuinty, Michaeline; Nakashima, Kei; Schwartz, Ilan S; Slavin, Monica; So, Miranda; Tan, Darrell H; Yong, Michelle. An international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP Platform, 1 683 000$/5 ans
- Sebastiani, Giada; Bajaj, Harpreet S; Betel, Michael; Kim, James W; Poder, Thomas G; Ramji, Alnoor; Saeed, Sahar Z. ELITE-2D: Enhancing Liver Health for People with Type 2 Diabetes through Patient-Centered Strategies, 210 000$/2 ans
Pour plus d'informations, visitez le site des IRSC.
